Literature DB >> 18798027

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.

Anne Prel1, Ghislaine Le Gall-Reculé, Véronique Jestin.   

Abstract

Infections with H5/H7 low-pathogenic avian influenza (LPAI) viruses are now notifiable because such viruses can mutate into highly pathogenic avian influenza viruses, leading to serious problems for both animal and public health. Domestic ducks can play a crucial role in the transmission of H5 LPAI viruses to other poultry. Although prime boost vaccination using, respectively, a recombinant vaccine and an inactivated vaccine was shown to be protective in ducks against H5N1 highly pathogenic avian influenza, vaccination of domestic ducks against H5 LPAIV is poorly documented. However, substituting inactivated vaccines with subunit vaccines might be more advantageous. In this context, we generated a triple recombinant baculovirus composed of HA and NA proteins derived from a French H5N3 LPAI virus strain and the M protein derived from an Italian H7N1 LPAI virus strain. We describe a molecular construction strategy that enabled the development of virus-like particles (VLPs). Western blot analyses and neuraminidase inhibition assay of cell supernatants purified by sucrose density gradient ultracentrifugation showed that HA, NA and M1 proteins were expressed and co-released. Electron microscopy examination revealed VLPs that were morphologically identical to wild-type virus. Immunogold electron microscopy demonstrated that H5 and N3 proteins were present on the VLP surface, and haemagglutination and neuraminidase assays showed that the H and N proteins, respectively, were biologically active. In addition, VLP immunogenicity (induction of haemagglutination-inhibiting antibodies) was demonstrated in specific pathogen free Muscovy ducks. According to our successful previous experimental results of protection in ducks following vaccination with the three baculovirus-expressed proteins, the present results make feasible the reliable use of H5N3 VLPs as a subunit vaccine in this species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798027     DOI: 10.1080/03079450802357001

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  8 in total

1.  Protective efficacy of a single dose of baculovirus hemagglutinin-based vaccine in chickens and ducks against homologous and heterologous H5N1 virus infections.

Authors:  Eun Hye Park; Byung Min Song; Jung Yum; Ji An Kim; Seung Kyoo Oh; Hyun Soo Kim; Gil Jae Cho; Sang Heui Seo
Journal:  Viral Immunol       Date:  2014-09-11       Impact factor: 2.257

2.  H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.

Authors:  Dong-Hun Lee; Jae-Keun Park; Yu-Na Lee; Jae-Min Song; Sang-Moo Kang; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Vaccine       Date:  2011-04-02       Impact factor: 3.641

Review 3.  Influenza vaccines based on virus-like particles.

Authors:  Sang-Moo Kang; Jae-Min Song; Fu-Shi Quan; Richard W Compans
Journal:  Virus Res       Date:  2009-04-15       Impact factor: 3.303

4.  Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.

Authors:  Jae-Keun Park; Dong-Hun Lee; Ha-Na Youn; Myeong-Seob Kim; Yu-Na Lee; Seong-Su Yuk; Tae-Hyun Lim; Jun-Hyuk Jang; Jung-Hoon Kwon; Byoung-Yoon Kim; Sang-Moo Kang; Baik-Lin Seong; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Influenza Other Respir Viruses       Date:  2012-06-21       Impact factor: 4.380

Review 5.  Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.

Authors:  Stanislav Sokolenko; Steve George; Andreas Wagner; Anup Tuladhar; Jonas M S Andrich; Marc G Aucoin
Journal:  Biotechnol Adv       Date:  2012-01-28       Impact factor: 14.227

Review 6.  Use of baculovirus expression system for generation of virus-like particles: successes and challenges.

Authors:  Fuxiao Liu; Xiaodong Wu; Lin Li; Zengshan Liu; Zhiliang Wang
Journal:  Protein Expr Purif       Date:  2013-06-03       Impact factor: 1.650

7.  H9N2 avian influenza virus in Korea: evolution and vaccination.

Authors:  Dong-Hun Lee; Chang-Seon Song
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15

Review 8.  Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use.

Authors:  Dong-Hun Lee; Jae-Keun Park; Chang-Seon Song
Journal:  Clin Exp Vaccine Res       Date:  2014-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.